ANNABELLA VIDAL-RUIZ: Open Payments
NPI 1063867760 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,482 in 70 payments from 14 companies in 2025. Trend: 2023 $1,127 · 2024 $1,070 · 2025 $1,482
Food & beverage: $1,482
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 9 | $267 |
| Teva Pharmaceuticals USA, Inc. | 11 | $208 |
| E.R. Squibb & Sons, L.L.C. | 13 | $204 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $182 |
| Alkermes, Inc. | 8 | $146 |
| Lundbeck LLC | 5 | $131 |
| Janssen Pharmaceuticals, Inc | 2 | $73 |
| ABBVIE INC. | 3 | $60 |
| Supernus Pharmaceuticals, Inc. | 2 | $43 |
| Vanda Pharmaceuticals Inc. | 2 | $43 |
Products named: Auvelity, UZEDY, COBENFY, CAPLYTA, ARISTADA, ABILIFY ASIMTUFII, SPRAVATO, VRAYLAR.
Industry payments across IL — which companies pay providers there.
